,Age at SX,Consolidated Rev 7marker DX,POLE mutation,FIGO 2009,PrimarySurgeryA,Residual_Disease,Chemotherapy,Radiation,Censor recurrence,Time to Rec,Censor DSS,Censor OS,Follow-up durationsf10-1735,49.16666667,EC3,mut (P286R),Stage IA,TAHBSO,No,2,2,1,47,1,1,47sf11-4892,62.5,EC3,mut (T278M),Stage 3A,TAHBSO,No,2,2,1,2,1,1,2sf11-5508,56.33333333,EC3,mut (P286R),Stage 1A,TAHBSO,No,2,1,1,30,1,1,30sh08-36978,54.66666667,EC3,mut (S297F),Stage 1A,TAHBSO,No,2,2,1,58,1,1,58sf10-11669,53.41666667,EC3,mut (V411L),Stage 1B,TAHBSO,No,2,1,1,33,1,1,33sf08-13916,70.75,EC3,mut (P286R),Stage 1A,LAHBSO,No,2,2,1,48,1,1,48sf05-4954,76.16666667,EC3,mut (P286R),Stage 1A ,TAHBSO,No,2,2,1,95,1,0,95sf05-13491,56.75,EC3,mut (T278M),Stage 1A ,TaHBSO,No,2,2,1,31,1,1,311,64,EC3,wt,Stage 1A,LAVHBSO and bilat lymph node sampling,No,2,2,1,43,1,1,434,52,EC3,wt,"Stage 1B, FIGO grade 3",TAHBSO,No,2,1,1,31,1,1,315,62.33333333,EC3,wt,Stage IVB papillary serous carcinoma,TAHBSO,No,1,2,0,12,0,0,3111,69,EC3,wt,Stage IA Grade 3 endometrioid adenocarcinoma,TAHBSO,No,2,2,1,32,1,1,3214,37,EC3,wt,,,No,1,1,0,13,0,0,2615,47.91666667,EC3,wt,"Stage IIIC1, grade 3 endometrioid adenocarcinoma of the uterus",TAHBSO,No,1,1,1,38,1,1,3816,53.08333333,EC3,wt,"Stage 1B, FIGO grade III Invasive endometrioid adenocarcinoma",TAHBSO,No,1,1,1,26,1,1,2620,56.25,EC3,wt,Stage IIIC2 Grade 3 endometrioid adenocarcinoma of the endometrium,TAHBSO,No,1,1,0,10,1,1,3522,62.33333333,EC3,wt,Stage IA Mixed serous and endometrioid adenocarcinoma,TAHBSO,No,2,2,1,32,1,1,3228,64.06849315,EC3,wt,Stage IB Grade 3 Endometrioid Adenocarcinoma,TAHBSO,No,2,1,1,36,1,1,3633,60.41666667,EC3,wt,Stage IA serous carcinoma of the uterus,BilatBSO,No,1,2,1,37,1,1,3734,74.58333333,EC3,wt,"Stage IIB, FIGO grade 3, endometrioid adenocarcinoma of the uterus.",TAHBSO,No,2,1,1,93,1,1,9335,58.16666667,EC3,wt,Stage IIIC2 high-grade serous adenocarcinoma of the uterus,TAHBSO,Yes,1,2,0,7,0,0,1737,51.5,EC3,wt,Stage IIIC2 Grade 3 endometrioid adenocarcinoma of the endometrium,LAVHBSO,No,1,,0,26,1,1,3843,38.5,EC3,wt,,,No,2,2,1,8,1,1,850,62.33333333,EC3,wt,"Stage IB, Grade 3 adenocarcinoma of the uterus",TAHBSO,No,2,2,1,58,1,1,5851,57.25,EC3,wt,"Stage IB, Grade 3 adenocarcinoma of the uterus",TAHBSO,No,2,2,1,14,1,0,1453,68.08333333,EC3,wt,"Stage IIIB, FIGO grade 3 endomerioid adenocarcinoma","Resection of cervical mass, D&C",No,1,1,0,7,0,0,754,60,EC3,wt,"Stage IIB, FIGO grade 3, endometrioid adenocarcinoma of the uterus.",TAHBSO,No,1,1,1,31,1,1,3156,44.41666667,EC3,wt,Stage IIIC high grade endometrioid adenocarcinoma of the uterus,TAHBSO,No,1,1,0,6,0,0,3361,51.66666667,EC3,wt,Stage IA Grade 3 endometrioid adenocarcinoma,TAHBSO,No,,2,1,10,1,1,1067,64.16666667,EC3,wt,"Stage IC, Grade 3 serous/endometriod adenocarcinoma",TAHBSO,No,1,2,1,61,1,1,6168,59.58333333,EC3,wt,Stage 1C Endometrioid Adenocarcinoma FIGO III,TAHBSO,No,2,1,1,47,1,1,4772,73.75,EC3,wt,,,No,1,2,0,7,0,0,778,64.24,EC3,wt,,,No,2,1,1,34,1,1,3479,77.66666667,EC3,wt,"Stage IIIA, Grade 3 endometrioid adenocarcinoma",SubAHBSO,No,1,2,0,8,0,0,881,62.66666667,EC3,wt,Stage IC Grade 2 adenocarcinoma of the uterus,TAHBSO,No,2,2,0,48,0,0,4882,68.5,EC3,wt,Stage IC Grade 3 endometrioid adenocarcinoma,TAHBSO,No,2,2,1,80,1,1,8085,56.16666667,EC3,wt,Stage IIIC mixed endometriod/serous/clear cell adinocarcinoma,TAHBSO,No,1,2,0,10,0,0,1086,83.5,EC3,wt,Stage IIIC Grade 3 endometrioid adenocarcinoma of the endometrium,TAHBSO,No,1,2,1,97,1,1,9787,61.16666667,EC3,wt,"Stage IB, Grade 3 adenocarcinoma of the endometrium",TAHBSO,No,2,2,1,75,1,1,7589,65.41666667,EC3,wt,Stage IB clear cell carcinoma,TAHBSO,No,2,2,1,79,1,1,7990,84.33333333,EC3,wt,"Stage IB, Grade 3 adenocarcinoma of the uterus",TAHBSO,No,2,2,1,69,1,1,6992,73.41666667,EC3,wt,Stage IIIC endometrioid adenocarcinoma/papillary serous component,TAHBSO,No,1,2,0,16,0,0,1893,60.16666667,EC3,wt,"Stage IIIC, Grade 3 endometriod adenocarcinoma",TAHBSO,Yes,1,1,0,8,0,0,894,77.25,EC3,wt,Stage IVB serous carcinoma of the uterus.,TAHBSO,No,1,2,0,54,0,0,5496,79.91666667,EC3,wt,Stage IVB poorly differentiated adenocarcinoma of the uterus,TAHBSO,No,1,2,1,87,1,1,8798,61.58333333,EC3,wt,Stage IA clear cell carcinoma of the uterus,TAHBSO,No,2,2,1,87,1,1,87102,63.5,EC3,wt,Stage IIIA Grade 3 endometrioid adenocarcinoma of the endometrium.,TAHBSO,No,1,2,1,78,1,1,78106,39.16666667,EC3,wt,Stage IA Grade 3 Mixed tumor of the endometrium confined to a polyp with an endometrioid carcinoma and with a neuroendocrine component,TAHBSO,No,2,2,1,90,1,1,90108,62,EC3,wt,"Stage IIB, FIGO grade 3, endometrioid adenocarcinoma of the uterus.",TAHBSO,No,2,1,1,91,1,1,91110,57.58333333,EC3,wt,Stage IIIC clar cell carcinoma of the endometrium,TAHBSO,No,1,1,0,16,0,0,19113,58.16666667,EC3,wt,Stage IA Grade 3 endometrioid adenocarcinoma,TAHBSO,No,2,2,1,84,1,1,84114,70.91666667,EC3,wt,Stage IVB papillary serous carcinoma,TAHBSO,No,1,2,0,72,1,1,80116,87.91666667,EC3,wt,Stage IIIC papillary serous carcinoma of the uterus,SubtotalAHBSO,No,2,2,1,3,1,0,3